Rights and permissions
About this article
Cite this article
The NMDA receptor antagonist memantine ameliorates the clinical decline of patients with moderate-to-severe Alzheimer's disease. Inpharma Wkly. 1247, 9 (2000). https://doi.org/10.2165/00128413-200012470-00020
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200012470-00020